- Global Pharma News & Resources

Genomics Market Historical Analysis, Regional Trends, Sales Revenue and Forecast 2022 to 2029

Washington, (10-01-2022) – announces the release of the report “Genomics Market ” Size, Share & Trends Analysis Report By 2029. To understand the market in depth, Research report is the perfect solution. With the specific base year and the historic year, estimations and calculations are performed in the report. This industry analysis report is generated with the combination of best industry insight, practical solutions, talent solutions and latest technology. This global market research report studies the market at regional and global level by considering major geographical areas. The analysis and forecasting of market data using best statistical and coherent models, market share analysis and key trend analysis are the major accomplishing factors in this wonderful Genomics Market report.

A comprehensive Genomics Market document considers various factors that have great effect on the growth of business which includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the industry. All the data and information involved in the report is taken from incredibly trustworthy sources such as websites, annual reports of the companies, white papers, journals, newspapers, and mergers. An international Genomics Market report also makes available statistics on the current state of the industry as a valuable source of guidance and direction for companies and investors interested in this market.

The genomics market is expected to witness market growth at a rate of 17.75% in the forecast period of 2021 to 2028. Data Bridge Market Research report on genomics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The expansion of healthcare sector globally is escalating the growth of genomics market.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @

Major Players:-

General Electric, Danaher, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Qiagen, Merck & Co., Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Genotypic Technology Pvt Ltd, Macrogen, Inc., Eurofins Genomics LLC, PerkinElmer Inc., Personalis Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies., Eppendorf AG, Novogene Corporation, SciGenom Labs Pvt. Ltd, Takara Holdingd Inc., Kohlberg Kravis Roberts & Co. L.P., Dnastar and New England Biolabs, among other domestic and global players.

Competitive Landscape and Genomics Market Share Analysis

The genomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to genomics market.

Genomics refers to the study of genomes and their communication with different stimuli, which is focus of development activities. Genomics is considered one of the reasons behind the rise in technologies providing a better apprehension of genomes and a better understanding of interaction of genomics.

The rise in the government funding to support genomics projects across the globe acts as one of the major factors driving the growth of genomics market. The surge in incidence of cancer and increasing applications of next-generation sequencing in cancer research, and advent of genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases accelerate the market growth. The use of multiomic-based approaches and genome-wide association studies (GWAS) for discovering biological networks and common variants underlying host-pathogen interactions, and utilization of genomics for even deciphering COVID-19 complications, resistance, and susceptibility further influence the market. Additionally, development in healthcare infrastructure, increase in healthcare spending and surge in government funding to support genomics projects, positively affects the genomics market. Furthermore, use of genomics in specialized/personalized medicine extend profitable opportunity to the market players in the forecast period of 2021 to 2028.

On the other hand, high cost associated with the genomic equipment and lack of trained professionals are expected to obstruct the market growth. Issues in securing storage of large volumes of sequenced data are projected to challenge the genomics market in the forecast period of 2021-2028.

This genomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.

Genomics Market Scope and Market Size

The genomics market is segmented on the basis of deliverables, technology, process, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of Deliverables, the genomics market is segmented into Product and Services. Product is further segmented into Reagents and Instruments. Services are further segmented into Core Genomics, NGS-Based, Biomarker Translation, Computational and Others.
  • On the basis of technology, the genomics market is segmented into sequencing, microarray, PCR, nucleic acid extraction and purification.
  • On the basis of process, the genomics market is segmented into sequencing, library preparation, and data analysis.
  • On the basis of Application, the genomics market is segmented into epigenomics, functional, biomarker discovery, and pathway analysis. Epigenomics are further segmented into chromatin immunoprecipitation, bisulfite sequencing, methylated DNA immunoprecipitation, chromatin accessibility assays, high-resolution melt and microarray analysis. Functional is further segmented into real-time PCR, transfection, RNA interference, SNP analysis and mutational analysis. Biomarker discovery is further segmented into real-time PCR, mass spectrometry, microarray analysis, bioinformatics, statistical analysis and DNA sequencing. Pathway analysis is further segmented into microarray analysis, bead-based analysis, real-time PCR, proteomics tools and others.
  • On the basis of end-user, the genomics market is segmented into government and academic institutes, clinical research, biotechnology and pharmaceutical companies, hospitals and clinics, and others.

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Market Overview
  4. Executive Summary
  5. Premium Insights
  6. By Component
  7. Product Type
  8. Delivery
  9. Industry Type
  10. Geography
    • Overview
    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Middle East & Africa
  11. Company Landscape
  12. Company Profiles
  13. Related Reports

For More Insights Get FREE Detailed TOC @

Global Genomics Market Country Level Analysis

The genomics market is analysed and market size insights and trends are provided by country, deliverables, technology, process, application, and end-user as referenced above.

The countries covered in the genomics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genomics market because of the increase in the number of research programs, and high number of strategic partnerships within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the increasing adoption of genomic technologies owing to the initiation of various research programs in the region.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The genomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for genomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genomics market. The data is available for historic period 2010-2019.

Read More @

About Data Bridge Market Research: 

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @

Editor Details

  • Company:
    • The Wire Times
Last Updated: 10-Jan-2022